Psilocybin
-
healthSaskatchewan MP Proposes Legislation to Expand Psilocybin Therapy Access
A new Canadian bill seeks to bypass bureaucratic hurdles for psilocybin-assisted therapy, allowing direct prescriptions for PTSD and depression treatment.
-
healthAlzheimer's Patient Regains Function After Psilocybin Treatment
A case report reveals a woman with advanced Alzheimer's regained speech and memories following psilocybin mushroom use, marking a potential medical breakthrough.
-
healthMagic Mushrooms Temporarily Reverse Alzheimer's Symptoms in Case Study
A woman with advanced Alzheimer's regained speech, memories, and mobility after psilocybin therapy, per a new case report in Frontiers in Neuroscience.
-
healthPsilocybin Shows Promising Effects on Alzheimer’s Patient in Brazil
A case study reports that a high dose of psilocybin temporarily improved symptoms in an advanced Alzheimer's patient, sparking interest in psychedelic research.
-
healthPsychedelics: A New Frontier in Mental Health Treatment
Psychedelic-assisted therapies show promise for treatment-resistant mental illness, with psilocybin leading trials as a potential FDA-approved treatment.
-
healthSingle Psilocybin Dose Reshapes Brain Function and Anatomy
A 2026 study found that a single 25 mg dose of psilocybin induces measurable brain changes for up to a month, boosting entropy and altering white matter.
-
healthPsilocybin’s Lasting Brain Rewiring: A Single Dose Linked to Month-Long Well-Being
New study shows a single 25mg psilocybin dose can 'loosen' brain patterns, improving mental well-being for up to a month via increased brain entropy.
-
healthTrump Accelerates Research on Psychedelic Drugs for Mental Health
President Trump signs an executive order to fast-track research into psychedelic drugs like psilocybin and ibogaine for treating mental health conditions, particularly in veterans.